Torren Management
RPRX icon

Torren Management’s Royalty Pharma RPRX Stock Holding History

Torren Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16.6K Hold
285
– – 0.01% 162
2026
Q2 		$16K Hold
285
– – 0.01% 164
2026
Q1 		$13.7K Sell
285
-109
-28% -$4.77K 0.01% 160
2025
Q4 		$15.2K Buy
+394
New +$15K 0.01% 655

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
New South Capital Management
New South Capital Management Memphis, Tennessee $1.53B AUM 36.31% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return

Torren Management's RPRX Position: Q3 2026 in Review

Torren Management held its Royalty Pharma (RPRX) position steady in Q3 2026 at 285 shares worth $16.6K. The position accounts for 0.01% of the portfolio, ranked #162.

Torren Management first reported a position in RPRX in Q4 2025 and has held it in 4 quarters since. 316 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Torren Management held 285 shares of Royalty Pharma worth $16.6K as of Q3 2026.
  • Torren Management left its Royalty Pharma share count unchanged in Q3 2026.
  • Royalty Pharma made up 0.01% of Torren Management's portfolio in Q3 2026, its #162 holding.
  • Torren Management first reported a position in Royalty Pharma in Q4 2025 and has held it in 4 quarters since.
  • 316 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Torren Management's 13F filing for Q3 2026, filed 29 Oct 2026.